Drugs tested to shield frontline workers from COVID
NCT ID NCT04344379
Summary
This study tested whether two existing drugs, azithromycin and hydroxychloroquine, could prevent COVID-19 infection in hospital workers frequently exposed to the virus. Over 120 healthcare workers who tested negative for the virus were randomly assigned to receive one of the drugs or a placebo pill for 40 days. Researchers tracked who became infected to see if either drug offered protective benefits against catching the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARS COV 2 INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopial Avicenne
Bobigny, 93000, France
-
Hôpital Broca
Paris, 75013, France
-
Hôpital Cochin
Paris, 75014, France
-
Hôpital GHU Paris Saclay
Le Kremlin-Bicêtre, 92100, France
-
Hôpital La Pitié-Salpétrière
Paris, 75013, France
-
Hôpital Necker
Paris, 75015, France
-
Hôpital Saint Antoine
Paris, 75012, France
-
Hôpital européen Georges Pompidou
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.